Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 46, 2022 - Issue 5
84
Views
0
CrossRef citations to date
0
Altmetric
Brief Communications

Sickle Cell Disease and Quality of Life: An Evaluation of Reporting of Patient-Reported Outcomes in Randomized Controlled Trials

, ORCID Icon, , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 265-268 | Received 20 Dec 2021, Accepted 06 Apr 2022, Published online: 21 Oct 2022

References

  • Knisely MR, Pugh N, Kroner B, et al. Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: report from the sickle cell disease implementation consortium. Am J Hematol. 2020;95(9):1066–1074.
  • The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46(12):1569–1585.
  • Edwards CL, Green M, Wellington CC, et al. Depression, suicidal ideation, and attempts in black patients with sickle cell disease. J Natl Med Assoc. 2009;101(11):1090–1095.
  • Salinas Cisneros G, Thein SL. Recent advances in the treatment of sickle cell disease. Front Physiol. 2020;11(435):435.
  • Brundage M, Blazeby J, Revicki D, et al. Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res. 2013;22(6):1161–1175.
  • Calvert M, Blazeby J, Altman DG, et al. Reporting of patient-reported outcomes in randomized trials. JAMA. 2013;309(8):814–822.
  • Mercieca-Bebber R, Friedlander M, Calvert M, et al. A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice. J Patient Rep Outcomes. 2017;1(1):5.
  • Chakraborty R, Cannella L, Cottone F, et al. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review. Lancet Haematol. 2020;7(12):e892–e901.
  • Efficace F, Fayers P, Pusic A, et al. European organization for research and treatment of cancer quality-of-live group (patient-reported outcome measurements over time in oncology registry). Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: a pooled analysis of 557 trials. Cancer. 2015;121(18):3335–3342.
  • Murad MH, Wang Z. Guidelines for reporting meta-epidemiological methodology research. Evid Based Med. 2017;22(4):139–142.
  • Cochrane 20 video series; [cited 2021 Jul 23]. Available at: https://training.cochrane.org/resource/cochrane-20-video-series.
  • Turner L, Shamseer L, Altman DG, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012;11:MR000030.
  • Bylicki O, Gan HK, Joly F, et al. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. Ann Oncol. 2015;26(1):231–237.
  • Calvert M, Brundage M, Jacobsen PB, et al. The CONSORT patient-reported outcome (PRO) extension: implications for clinical trials and practice. Health Qual Life Outcomes. 2013;11:184.
  • Machado RF, Barst RJ, Yovetich NA, et al. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood. 2011;118(4):855–864.
  • Derchi G, Forni GL, Formisano F, et al. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica. 2005;90(4):452–458.
  • Machado RF, Martyr S, Kato GJ, et al. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol. 2005;130(3):445–453.
  • Guyatt GH, Naylor CD, Juniper E, et al. Evidence-based medicine working group. users’ guides to the medical literature: XII. How to use articles about health-related quality of life. JAMA. 1997;277(15):1232–1237.
  • Sprangers MAG, Moinpour CM, Moynihan TJ, et al. Assessing meaningful change in quality of life over time: a users’ guide for clinicians. Mayo Clin Proc. 2002;77(6):561–571.
  • Mercieca-Bebber R, Rouette J, Calvert M, et al. International Society for Quality of Life Research (ISOQOL) best practice for pros-reporting taskforce. Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension. Qual Life Res. 2017;26(6):1427–1437.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.